Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 21, 2023
Event: Entry into a Material Definitive Agreement involving a private placement of debt securities.
Key Financial Metrics
- Debt Issuance: Asset-Backed Secured Promissory Notes with an aggregate principal amount of $4.6 million.
- Proceeds Received: Approximately $3.0 million (issued at a 33.33% original issue discount).
- Interest Rate: 0% per annum.
- Maturity Date: January 21, 2023 (Note: The filing text states this date, which precedes the issuance date of July 21, 2023).
- Collateral: Secured by a Security Agreement in favor of the Purchasers.
- Subordination: Rights are subordinate to NH Expansion Credit Fund Holdings LP.
Material Changes and Transaction Details
The Company completed a private placement on July 21, 2023, selling notes to accredited investors exempt from registration under Section 4(a)(2) of the Securities Act. The transaction included the following material agreements:
- Security Agreement: Secures the Company's obligations under the Notes.
- Subordination Agreement: Establishes priority of payments to NH Expansion Credit Fund Holdings LP over the new Purchasers.
- Side Letter: Outlines future obligations upon the Maturity Date, including the issuance of a Future Advance Convertible Promissory Note and two Common Stock Purchase Warrants per Purchaser.
Guidance, Outlook, and Unusual Items
Future Obligations: Upon the Maturity Date, the Company agreed to issue each Purchaser:
- A Future Advance Convertible Promissory Note with a principal amount equal to the original Note plus accrued interest.
- Two Common Stock Purchase Warrants:
- Warrant 1: Exercise price of $0.04 per share.
- Warrant 2: Exercise price of $0.067 per share.
- Warrant share calculation: Principal amount of the Future Advance Note divided by $0.04.
Unusual Items: The filing text lists the Maturity Date as January 21, 2023, which is prior to the issuance date of July 21, 2023. This appears to be a clerical error in the source text; the filing does not provide a corrected maturity date.
Investor Verification Checklist
- Verify the correct Maturity Date, as the text lists a date prior to issuance.
- Review the full text of the Side Letter (Exhibit 10.3) to confirm the specific terms of the Future Advance Convertible Promissory Note and Warrants.
- Assess the impact of the subordination to NH Expansion Credit Fund Holdings LP on repayment priority.
- Confirm the dilution impact of the warrants with exercise prices of $0.04 and $0.067.
- Examine the Security Agreement (Exhibit 10.1) to understand the specific assets pledged as collateral.